| Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma J Kiyasu, H Miyoshi, A Hirata, F Arakawa, A Ichikawa, D Niino, Y Sugita, ... Blood, The Journal of the American Society of Hematology 126 (19), 2193-2201, 2015 | 490 | 2015 |
| Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: Histology, E pstein–B arr virus, and clonality are important predictors of disease progression … A Ichikawa, F Arakawa, J Kiyasu, K Sato, H Miyoshi, D Niino, Y Kimura, ... European journal of haematology 91 (1), 20-28, 2013 | 266 | 2013 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martín-García, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 181 | 2018 |
| Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling Y Watatani, Y Sato, H Miyoshi, K Sakamoto, K Nishida, Y Gion, Y Nagata, ... Leukemia 33 (12), 2867-2883, 2019 | 180 | 2019 |
| PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma H Miyoshi, J Kiyasu, T Kato, N Yoshida, J Shimono, S Yokoyama, ... Blood, The Journal of the American Society of Hematology 128 (10), 1374-1381, 2016 | 127 | 2016 |
| Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas K Kataoka, H Miyoshi, S Sakata, A Dobashi, L Couronné, Y Kogure, ... Leukemia 33 (7), 1687-1699, 2019 | 126 | 2019 |
| Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma M Fujisawa, M Sakata-Yanagimoto, S Nishizawa, D Komori, P Gershon, ... Leukemia 32 (3), 694-702, 2018 | 120 | 2018 |
| Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients K Kawamoto, H Miyoshi, N Yoshida, J Takizawa, H Sone, K Ohshima The American journal of surgical pathology 40 (11), 1473-1483, 2016 | 103 | 2016 |
| Identification of cell-type-specific mutations in nodal T-cell lymphomas TB Nguyen, M Sakata-Yanagimoto, Y Asabe, D Matsubara, J Kano, ... Blood cancer journal 7 (1), e516-e516, 2017 | 87 | 2017 |
| Prognostic value of programmed death ligand 1 and programmed death 1 expression in thymic carcinoma S Yokoyama, H Miyoshi, K Nakashima, J Shimono, T Hashiguchi, ... Clinical Cancer Research 22 (18), 4727-4734, 2016 | 85 | 2016 |
| Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors D Kurita, H Miyoshi, A Ichikawa, K Kato, Y Imaizumi, R Seki, K Sato, ... The American Journal of Surgical Pathology 43 (7), 869-884, 2019 | 79 | 2019 |
| Clinicopathological analysis of a composite lymphoma containing both T‐and B‐cell lymphomas N Suefuji, D Niino, F Arakawa, K Karube, Y Kimura, J Kiyasu, M Takeuchi, ... Pathology International 62 (10), 690-698, 2012 | 73 | 2012 |
| Clinicopathologic and prognostic implications of programmed death ligand 1 expression in thymoma S Yokoyama, H Miyoshi, T Nishi, T Hashiguchi, M Mitsuoka, S Takamori, ... The Annals of thoracic surgery 101 (4), 1361-1369, 2016 | 66 | 2016 |
| A high RORγT/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and … N Yoshida, T Kinugasa, H Miyoshi, K Sato, K Yuge, T Ohchi, S Fujino, ... Annals of surgical oncology 23, 919-927, 2016 | 59 | 2016 |
| A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features K Kawamoto, H Miyoshi, T Suzuki, Y Kozai, K Kato, M Miyahara, T Yujiri, ... Haematologica 103 (6), 1018, 2018 | 58 | 2018 |
| Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression … H Miyoshi, K Sato, D Niino, F Arakawa, Y Kimura, J Kiyasu, M Takeuchi, ... American journal of clinical pathology 137 (6), 879-889, 2012 | 58 | 2012 |
| Epidemiology and secular trends of malignant lymphoma in Japan: analysis of 9426 cases according to the World Health Organization classification R Muto, H Miyoshi, K Sato, T Furuta, H Muta, K Kawamoto, E Yanagida, ... Cancer medicine 7 (11), 5843-5858, 2018 | 57 | 2018 |
| Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma K Shimada, K Yoshida, Y Suzuki, C Iriyama, Y Inoue, M Sanada, ... Blood, The Journal of the American Society of Hematology 137 (11), 1491-1502, 2021 | 56 | 2021 |
| MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B‐cell lymphoma K Kawamoto, H Miyoshi, N Yoshida, N Nakamura, K Ohshima, H Sone, ... Cancer science 107 (6), 853-861, 2016 | 53 | 2016 |
| Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma H Miyoshi, K Sato, Y Kabeya, S Yonezawa, H Nakano, Y Takeuchi, ... Laboratory Investigation 100 (10), 1300-1310, 2020 | 51 | 2020 |
